Related Experiment Videos
[Patient management following cardiac transplantation]
C Seydoux1, D G Berguer, F Stumpe
1Division de cardiologie, Centre hospitalier universitaire vaudois, Lausanne.
Insights
Cyclosporine has greatly improved heart transplant patient survival and quality of life. Careful management of complications like rejection and renal failure is crucial for long-term success.
Area of Science:
- Cardiology
- Immunosuppression
- Transplantation
Context:
- Heart transplantation outcomes have improved due to cyclosporine.
- Optimal patient follow-up is key for managing complications and enhancing quality of life.
- Despite advancements, complication incidence remains high, requiring specialized care.
Purpose:
- To review heart transplantation outcomes and complications at a specific center.
- To detail common post-transplant issues including rejection, transplant coronary artery disease, hypertension, renal failure, metabolic disorders, cancer, and conduction problems.
- To emphasize the importance of multidisciplinary medical team cooperation for long-term transplant program success.
Summary:
- Cyclosporine has significantly enhanced heart transplant patient prognosis and quality of life.
- Key complications include rejection, transplant coronary artery disease, hypertension, renal failure, metabolic disorders, cancer, and conduction issues.
- Multidisciplinary collaboration among cardiologists, surgeons, anesthetists, and general practitioners is vital for successful long-term outcomes.
Impact:
- Improved understanding of heart transplant complications and their management.
- Highlights the critical role of immunosuppression and vigilant monitoring.
- Underscores the necessity of a coordinated medical team approach for sustained patient well-being and program efficacy.
Abstract:
Prognosis of heart transplant patients has dramatically improved in the last decade thanks to the use of cyclosporine as immunosuppressive treatment. Optimal follow-up and early recognition of complications and side effects of treatment lead to longer survival and marked improvement of these patients' quality of life. However, the incidence of complications remains high and their management calls for particular care. We review our experience of heart transplantation in Lausanne and describe in detail the results and complications such as rejection, transplant coronary artery disease, hypertension, renal failure, metabolic disorders, cancer and conduction problems. Cooperation of the medical team (cardiologist, surgeon, anesthetist, general practitioner) is essential to long term success of the transplant program.